Optimizing treatment in head and neck cancers -- are molecular markers the answer?
D'cruz
Anil K
AK
Surgery Department, Tata Memorial Hospital, Mumbai, India. adcruz@vsnl.com
Mulherkar
Rita
R
D014408:Biomarkers, Tumor; D064420:Drug-Related Side Effects and Adverse Reactions; D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D011878:Radiotherapy / Q000009:adverse effects*; D012307:Risk Factors
D014408:Biomarkers, Tumor